STIM1 and Alzheimer disease: Furthermore, we shed light on the mechanisms underlying these changes and provide a proof-of-principle approach to rescue astrocyte-dependent synaptic plasticity, suggesting the astrocyte Ca2+ sensor stromal interaction molecule 1 (STIM1) as a therapeutic target in the context of AD.